Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001140361-15-037181

Chief Executive Officer acquired 80 shares (other)

  • Chief Executive Officer acquired 2,672 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Leuthner Brian A · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-10-06 Conversion : show line 1 in the form +2,672 550,878 D
2015-10-06 Other acquisition : show line 2 in the form +80 $8.60 $688 550,958 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2015-10-06 Conversion : show line 3 in the form Series C-2 Convertible Preferred Stock −3,655 2,672 0 D
Loading xslF345X03/doc1.xml…